Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Other: Review of clinical records
- Registration Number
- NCT00895050
- Lead Sponsor
- Pfizer
- Brief Summary
The primary purpose of this study is to evaluate a computer-based tool on the clinical management of patients with rheumatoid arthritis in Spain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 321
Inclusion Criteria
Main Inclusion Criteria:
- Patients, male or female, over 18 years old.
- Patients diagnosed with RA according to investigator criteria
- Patients with a disease evolution >= 1 year
- Patients with > = 5 affected joints
Exclusion Criteria
Exclusion Criteria:
- Patients with other muscle skeletal, rheumatic and/or degenerative diseases different from RA.
- Patients who are taking part or have taken part in a clinical trial or in a study with drugs within the last 12 months. Any condition that, in the investigator's judgment would interfere with the subject's ability to comply with protocol requirements or give informed consent.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 Review of clinical records Patients diagnosed with RA
- Primary Outcome Measures
Name Time Method Global mean DAS28 at 6 and at 12 months of follow-up. Differences between global mean DAS28 at 6 and at 12 months compared to baseline 12 months
- Secondary Outcome Measures
Name Time Method Disease activity (DAS28; number affected joints; CRP; ESR; PGA).-Number of variables used in patient's follow-up; number of treatment adjustments. -Investigator's satisfaction with the computer-based tool (specific questionnaire) 12 months